Looking to the Future of Percutaneous Treatment of Patients with Valvular Heart Disease.
The development of transcatheter valvular therapeutics has revolutionized interventional cardiology over the past decade. Nonetheless, despite these prominent advances in percutaneous valve technology, numerous obstacles regarding safety and efficacy must be overcome before the precise clinical role of these devices becomes clear. This article discusses the current status of transcatheter valve replacement and repair as it pertains to the aortic and mitral valve and deliberates on the bright future of a promising tool that will drastically affect clinical interventional practice.